TIMOPTOL

This brand name is authorized in Australia, Brazil, Ecuador, France, Hong Kong, Ireland, Italy, Japan, Mexico, New Zealand, Singapore, United Kingdom

Active ingredients

The drug TIMOPTOL contains one active pharmaceutical ingredient (API):

1 Timolol UNII P8Y54F701R - TIMOLOL MALEATE

Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma. Read about Timolol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TIMOPTOL Eye drops, solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01ED01	Timolol	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1279H, 1926J, 5548B, 5550D
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525502303171319, 525502304178317, 556718030001707, 556718030001807
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 24.057-1-09-11
Country: FR	Base de données publique des médicaments	Identifier(s): 60396928, 61417407, 64190637, 64342874
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 146682, 146685, 14971, 15004, 162741, 162802, 34115, 34175
Country: HK	Department of Health Drug Office	Identifier(s): 02362
Country: IE	Health Products Regulatory Authority	Identifier(s): 74349, 74357
Country: IT	Agenzia del Farmaco	Identifier(s): 024278107, 024278121
Country: JP	医薬品医療機器総合機構	Identifier(s): 1319702Q1107, 1319702Q2111, 1319702Q3037, 1319702Q4033
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 0313M79
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 2749, 2750
Country: SG	Health Sciences Authority	Identifier(s): 04135P, 08619P